Matches in Wikidata for { <http://www.wikidata.org/entity/Q97559071> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q97559071 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97559071 description "scientific article published on 09 July 2020" @default.
- Q97559071 description "wetenschappelijk artikel" @default.
- Q97559071 description "наукова стаття, опублікована 9 липня 2020" @default.
- Q97559071 name "US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation" @default.
- Q97559071 name "US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation" @default.
- Q97559071 type Item @default.
- Q97559071 label "US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation" @default.
- Q97559071 label "US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation" @default.
- Q97559071 prefLabel "US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation" @default.
- Q97559071 prefLabel "US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation" @default.
- Q97559071 P1433 Q97559071-D9214F96-15CD-4CD4-9BBA-648CE99B4C54 @default.
- Q97559071 P1476 Q97559071-2AEDEF4C-F79E-4FDF-BFFD-5E4526EA439C @default.
- Q97559071 P2093 Q97559071-4DA39BA6-CB01-4428-98D2-F2C81F07A5E9 @default.
- Q97559071 P2093 Q97559071-F83A580A-CE5E-4BF0-88B5-962BCBAE9368 @default.
- Q97559071 P2860 Q97559071-173B20DC-54EB-4262-B150-0E4045EE0FA6 @default.
- Q97559071 P2860 Q97559071-4DB383FF-E0B7-4B92-BC33-B3E1108344A3 @default.
- Q97559071 P2860 Q97559071-52B02B08-1A58-47D0-9E2D-556E209AFC1C @default.
- Q97559071 P31 Q97559071-0C74CF52-66F5-4E14-8868-E6E00295486C @default.
- Q97559071 P356 Q97559071-6921E140-2DE2-4B71-AE61-3E567F806DA6 @default.
- Q97559071 P577 Q97559071-43DA3EEB-5293-408C-9C41-EFC71C277B8C @default.
- Q97559071 P698 Q97559071-DD44329A-D54A-47A8-AB71-EB06052CFB91 @default.
- Q97559071 P921 Q97559071-0BAC1B3E-A27A-4EF9-A24A-069F6571BC3E @default.
- Q97559071 P356 CNCR.33058 @default.
- Q97559071 P698 32644193 @default.
- Q97559071 P1433 Q326041 @default.
- Q97559071 P1476 "US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation" @default.
- Q97559071 P2093 "Myung Sun Kim" @default.
- Q97559071 P2093 "Vinay Prasad" @default.
- Q97559071 P2860 Q28141442 @default.
- Q97559071 P2860 Q34052075 @default.
- Q97559071 P2860 Q91694148 @default.
- Q97559071 P31 Q13442814 @default.
- Q97559071 P356 "10.1002/CNCR.33058" @default.
- Q97559071 P577 "2020-07-09T00:00:00Z" @default.
- Q97559071 P698 "32644193" @default.
- Q97559071 P921 Q1088156 @default.